ResMed Inc (RMD)
219.72
-2.90
(-1.30%)
USD |
NYSE |
Mar 28, 16:00
219.72
0.00 (0.00%)
After-Hours: 20:00
ResMed Enterprise Value: 32.85B for March 27, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 159.20B |
| Abbott Laboratories | 234.20B |
| Bio-Rad Laboratories Inc | 6.460B |
| Becton Dickinson & Co | 83.70B |
| Masimo Corp | 9.676B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 344.62M |
| Revenue (Quarterly) | 1.282B |
| Total Expenses (Quarterly) | 864.85M |
| EPS Diluted (Quarterly) | 2.34 |
| Gross Profit Margin (Quarterly) | 58.60% |
| Profit Margin (Quarterly) | 26.88% |
| Earnings Yield | 3.85% |
| Operating Earnings Yield | 4.81% |
| Normalized Earnings Yield | 3.870 |